Streetbeat News

Products Services

BA

Boeing's CFO announced during a conference call that the timeline for implementing anti-icing measures remains unchanged. Additionally, there is a plan to increase the production of the 787 model to 5 units per month later this year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:44 pm

BGNE

BeiGene's stock is trading higher following the European Commission's approval of Tislelizumab for non-small cell lung cancer, covering first- and second-line use.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:41 pm

BA

Boeing announced in a conference call that it expects to have largely delivered its 737 and 787 inventory by the end of this year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:39 pm

BA

SPR

Boeing announced during a conference call that enhanced quality control standards in Wichita are leading to more predictable and reduced cycle times in their factory. The company expects these improvements, which help the Spirit team prevent nonconformances, to continue.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:39 pm

BA

Boeing has announced during a conference call that it has engaged a team of quality experts to review its work processes. This move indicates the company's commitment to maintaining high standards of quality and safety in its operations.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:37 pm

AMST

ATXI

BOF

CSSE

EVO

GCTK

TSLA

Nasdaq rose 0.5% with Tesla shares jumping 10% after Q1 results, despite missing earnings and sales expectations. BranchOut Food, Amesite, and Chicken Soup for the Soul Entertainment saw significant gains, while Evotec, Avenue Therapeutics, and GlucoTrack experienced sharp declines. The article also highlights sector movements, with consumer discretionary shares up and industrials down.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 2:30 pm

PGEN

Precigen, Inc. (NASDAQ:PGEN) announced that clinical data from its Phase 2 study of PRGN-2012 AdenoVerse immunotherapy for treating recurrent respiratory papillomatosis (RRP) will be presented at the 2024 ASCO Annual Meeting. This novel treatment has shown to lead to complete and durable responses in RRP patients.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:22 pm

CMI

BAE Systems and Cummins Inc. have announced a collaboration to develop a hybrid electric drivetrain for transit buses, targeting a 2027 launch. This partnership aims to provide transit agencies with a cost-effective, emission-reducing technology. BAE Systems will supply electric drive hardware and engineering support, continuing their long history of developing electric propulsion systems for various vehicles. The collaboration builds on a relationship since 1994, focusing on sustainable transit solutions.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:07 pm

REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced it will present new and updated data from its oncology and hematology pipeline at the ASCO 2024 Annual Meeting. This includes 17 presentations on investigational treatments like REGN7075 in combination with Libtayo for advanced solid tumors, and other therapies targeting multiple myeloma, lymphoma, and various solid and blood cancers. The presentations will showcase Regeneron's progress in developing novel treatments for over 30 types of cancer.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:06 pm

IDYA

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) announced that interim results from a Phase 2 trial of darovasertib for uveal melanoma will be presented at ASCO 2024. The presentation is scheduled for June 3, 2024, with the abstract summary available on May 23, 2024. This marks a significant milestone in the development of darovasertib as a potential treatment for uveal melanoma.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:06 pm